Biomarker Accelerator Grant Program supports researchers validating and translating existing PSP biomarkers to improve diagnosis, disease monitoring, treatment-response assessment and clinical research.
Biomarker Accelerator Program supports researchers pursuing biomarker discoveries for progressive supranuclear palsy to accelerate diagnosis, treatment, research, or clinical care.
Parkinson's Disease Biomarker Innovation and Advancement Program supports teams developing fluid- and imaging-based biomarkers for clinical implementation and broader use in Parkinson's research.
Biomarker Research Grant: Diagnostic and Prognostic Biomarker Development for Myasthenia Gravis and Related Neuromuscular Junction Disorders funds researchers developing biomarkers to improve diagnosis and prognosis.
Bayer funds educational projects to advance treatment strategies and clinical trial innovations in metastatic hormone-sensitive prostate cancer (mHSPC).
The CURE SYNGAP1 Grants Program funds research to advance clinical trial readiness and treatment development for SYNGAP1-Related Disorders.